PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. CYTOCELL LIMITED
CY

CYTOCELL LIMITED

Cambridge
Large

OGT provides precision genomic solutions, specializing in hybridization-based FISH, NGS, and array products for various medical applications.

ogt.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£1.0m
Live
3
Buyers
2
12m
£517k
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts3 / 7
  • Top buyers2
  • Category mix
  • Geography
  • Peers
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — CYTOCELL LIMITEDUpdated 20 Jul 2026

At a glance · for buyers and watchdogs

CYTOCELL LIMITED has won £1.0m across 2 public-sector buyers, with 3 live contracts. No active Companies House risk flags.

Why: top buyer CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST at 82% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
3 of 7Live contracts
82%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 3
FISH SolutionsWorld-leading FISH solutions for haematological malignancies and cytogenetics. ↗NGS TechnologyInnovative NGS technology for cancer panel design and analysis. ↗Array ProductsHigh-quality aCGH products and custom array design. ↗

Extracted automatically from ogt.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 3 live · 4 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Upgrade and Expansion to Applied Spectral Imaging GenASIs Cytogenetics Scanning, Image Capture and Analysis Software System
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST—01 May 2026£424k12 mopending
Genomics Image Capture System Upgrade Licence
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST—21 Feb 2026£93k1 moClosed
Genomics Image Capture System Upgrade Licence
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST—21 Feb 2026£93k1 mopending
Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Upgrade and Expansion to Applied Spectral Imaging GenASIs Cytogenetics Scanning, Image Capture and Analysis Software System
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST—01 May 2026£424k12 mopending
Service & Maintenance
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST————Live
Supply, Delivery, Installation, Commissioning and Post-Warranty Maintenance of Upgrade and Expansion to Applied Spectral Imaging GenASIs Cytogenetics Scanning, Image Capture and Analysis Software System
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST————Live
Cytopower scaler
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST————Live
Total live value — · mean award £148k

Top buyers · 2 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST
5 contracts
82%
since 2026
2
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST
2 contracts
18%
since 2026

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Eastern5 contracts
82%
East Midlands2 contracts
18%

Peers

Suppliers with overlapping CPVs and buyers.

✓ From notices
≈

No close peers found

Not enough categorised awards yet to compute a comparable peer set.

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Mar 2025
Confirmation statement
Due in -34d
Next due 18 Jun 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
04231155
Status
Active
Type
Private limited
Incorporated
08 Jun 2001
Reg. office
Oxford Gene Technology 418 Cambridge Science Park, Milton Road, Cambridge, CB4 0PZ
SIC codes
86900
Last accounts
31 Mar 2025
Next accounts due
31 Dec 2026

Directors & PSC

  • IWAKABE, Kenji — director
    Appointed 07 May 2025
  • SMITH, Adrian Brian — director
    Appointed 28 Apr 2022
  • WILLIAMS, Gregory Alun — director
    Appointed 30 Jan 2019
  • LENHARDT, Anthony John — secretary
    Appointed 25 Feb 2016
  • Oxford Gene Technology Ip Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
CYTOCELL LIMITED
04231155 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.